The stats on the actual infection rates since the pandemic started are out this week and show that this virus was much more infective than expected.
The relevant part for us as bta investors is that the degree of immunity inferred by the wide spread but mild in most virus was vey low. In laymens terms - if you got it mildly so far - chances are you wont be immune to the next wave due (statistically in nth hemisphere week 1-2 feb)
Other main point is - the extremly wide infection rate will give a advantage to swine flu varients which are emerging currently.
third point - not many people have taken up the vaccine believing the pandemic is over - just as they did for the 1957 asian flu which went on to a third wave killing over 2 million people that yr
Conclusion - Anti virals will be main line of defense once again cementing stockpiling protocol for the future.
*** side note - i'm picking up increased flu activity emerging from eastern block mexico and brazil - we could be in for a re-boot of this epidemic - with general news media broadcasting the info in about 2-3 weeks --- watch this space
January 22, 2010
In London and the West Midlands, the difference in the proportion of samples with haemagglutination inhibition titre equal to or above 1:32 between baseline and September, 2009, was 213% (95% CI 88403) for children younger than 5 years of age, 420% (263582) for 514-year-olds, and 206% (16424) for 1524-year-olds..
Around one child in every three was infected with 2009 pandemic H1N1 in the first wave of infection in regions with a high incidence, ten times more than estimated from clinical surveillance.
H1N1 infections in children in England in the first wave were about 10 fold higher than levels reflected in clinical surveillance. However, it is likely that H1N1 infections were even higher than frequencies based on neutralizing antibody levels equal or above 32. Anecdotal reports of lab confirmed re-infections suggest initial infections did not produce protective antibody levels. Similarly, clinical trials in Australia indicated 31% of participants had titers of 40 or higher at baseline and most increased titers by at least four fold after vaccination, further indicating that initial infections did not produce robust titers.
In other countries such as the United States, the frequency in students in hard hit areas was markedly higher than 30-40%. Although schools were instructed to stay open if physically possible, many school districts closed because of absenteeism in faculty and staff. Those that remained open saw absenteeism rates were above 20% for extended periods of time. Since students were instructed to return to class after being fever free for 24 hours, many students were only absent 1-3 days. many were asymptomatic or without fever, so they were not absent. Consequently schools with double digit daily absenteeism for 1-2 weeks had a likely attack rate that approached 100%.
In many areas which had two waves, the target population of the second wave was somewhat older, suggesting a high percentage of the under 65 population was infected with H1N1. This widespread immunity will put pressure on the virus to grow at higher levels or escape from the immune response, leading to concerns of a more severe upcoming wave. Reports of receptor binding domain changes, especially at position 225 appear almost daily, raising concerns that this sub-clade could be transmitting at a much higher frequency in subsequent outbreaks. In some countries the cases fatality rate for D225G/N is at 100% and todays weekly epidemiological report indicates that over-all 50% of sequences with D225G are from fatal cases. Recent death clusters in Romania and Nepal raise concerns that the frequency in severe and fatal cases will be markedly higher in the next wave.
- Forums
- ASX - By Stock
- BTA
- h1n1 infection rate to impact relenza sales
h1n1 infection rate to impact relenza sales
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online